313 related articles for article (PubMed ID: 27826184)
1. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
Frias I; Neves AR; Pinheiro M; Reis S
Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
[TBL] [Abstract][Full Text] [Related]
3. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
Ramesh N; Mandal AKA
Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
[TBL] [Abstract][Full Text] [Related]
7. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems.
Granja A; Frias I; Neves AR; Pinheiro M; Reis S
Biomed Res Int; 2017; 2017():5813793. PubMed ID: 28791306
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
[TBL] [Abstract][Full Text] [Related]
10. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
[TBL] [Abstract][Full Text] [Related]
11. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
[TBL] [Abstract][Full Text] [Related]
12. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery.
Li W; Yalcin M; Lin Q; Ardawi MM; Mousa SA
J Control Release; 2017 Feb; 248():117-124. PubMed ID: 28077264
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
[TBL] [Abstract][Full Text] [Related]
15. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2010 Oct; 41(2):219-25. PubMed ID: 20600878
[TBL] [Abstract][Full Text] [Related]
16. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
17. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
20. Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection--synthesis, characterization and in vitro evaluation.
Mukherjee S; Ghosh S; Das DK; Chakraborty P; Choudhury S; Gupta P; Adhikary A; Dey S; Chattopadhyay S
J Nutr Biochem; 2015 Nov; 26(11):1283-97. PubMed ID: 26310506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]